Theratechnologies Inc T.TH

Calling a special meeting

[jeffm34]

     Special General Meeting Called at the Request of Shareholders. It shall be incumbent upon the Board of Directors to call a special general meeting of shareholders whenever required in writing to do so by the shareholders holding no less than one-tenth of the issued shares of the CompanyCorporation of the class or classes that, at the date of the request, carry the right to vote at the meeting so requested. The request shall indicate the purposes of the upcoming meeting, the business of which shall lie within the competence of a general meeting of the shareholders. If the meeting is not called and held within 21 days from the date upon which the request for the meeting was depositedreceived at the head office of the CompanyCorporation to the attention of the Corporate Secretary, everyany shareholder, whether or not it who signed the request, holding not less than one-tenth of the issued shares of the Company carrying the right to vote at the meeting requested may itself convenecall such special general meeting.

[jeffm34]

So it would require about 10M shares to be represented and then this requirement: The request shall indicate the purposes of the upcoming meeting, the business of which shall lie within the competence of a general meeting of the shareholders.

[palinc2000]

I respectfully disagree 100%....Waste of time and energy and money 

[jeffm34]

I think given their track record there is cause for concern. If I were a major shareholder, I would want to make my views very clear to management at this point. 

[palinc2000]

What would you want to make Clear?  

[jeffm34]

I can't speak for the major shareholders. My own personal views are that the NASH program should not proceed without a partner, no matter how creative they get in raising funds to do so. If there is a decent chance of success, other companies will be more than willing to validate the program by putting up their own cash. If no one steps forward it would be irresponsible of management to

[qwerty22]

So you want the company to publicly state that the partner they might be talking to is the only option on the table? How nice for the partner to know that when it comes to the negotiations. I just don't see them talking about any of their options publicly. It's not in the commercial interest of the company to do so while there is an active process in play.

[qwerty22]

I am as strongly against the moth-balling of the NASH program as I am against them making a terrible decision. Giving the future of that program is contingent on ongoing processes and future milestones that nobody can predict it just makes zero sense to tie down management at this point. Basically this comes down to whether you think management (and the board) have the best interest of the

[jeffm34]

It comes down to the probability of success in NASH.  I happen to think it's quite low.  If I'm wrong then TH will find a partner on favourable terms. If they don't find a partner then I'm probably right. 

[Bucknelly21]

Probably that he doesn't want to be diluted again for some low ball price 

[Bucknelly21]

Palinc, I'm curious if you had to give Paul a grade right now for the time he's been there what would it be?   be quote=palinc2000] What would you want to make Clear?     [/quote]

[palinc2000]

I was expecting better sales results but the pandemic  was a major obstacle,,Even though results are not there yet I applaud his  methodical approach to educate both patients and end users,,,This will pay off  With regards to the pipeline he has done a fantastic job,Just before he joined we were told that all was needed to go into Phase 3 for HIV NASHwas to harmonize FDA and EMA

[palinc2000]

oups b not end users ,,,I mean physicians [/quote]

[ANALIAS00]

I agree with Palinc